MapLight Therapeutics' CEO is Chris Kroeger, appointed in Jan 2018, has a tenure of 8.42 years. total yearly compensation is $25.62M, comprised of 2.6% salary and 97.4% bonuses, including company stock and options. directly owns 0.25% of the company’s shares, worth $3.34M. The average tenure of the management team and the board of directors is 5.1 years and 2.8 years respectively.
Key information
Chris Kroeger
Chief executive officer
US$25.6m
Total compensation
CEO salary percentage
2.56%
CEO tenure
8.4yrs
CEO ownership
0.3%
Management average tenure
5.1yrs
Board average tenure
2.8yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Chris Kroeger's remuneration changed compared to MapLight Therapeutics's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2026
n/a
n/a
-US$199m
Dec 31 2025
US$26m
US$655k
-US$161m
Sep 30 2025
n/a
n/a
-US$103m
Jun 30 2025
n/a
n/a
-US$92m
Mar 31 2025
n/a
n/a
-US$81m
Dec 31 2024
US$9m
US$628k
-US$78m
Mar 31 2024
n/a
n/a
-US$63m
Dec 31 2023
US$5m
US$602k
-US$56m
Compensation vs Market: Chris's total compensation ($USD25.62M) is above average for companies of similar size in the US market ($USD5.34M).
Compensation vs Earnings: Chris's compensation has increased whilst the company is unprofitable.
CEO
Chris Kroeger (58 yo)
8.4yrs
Tenure
US$25,624,254
Compensation
Dr. Christopher A. Kroeger, also known as Chris, M.D., Ph D., MBA is Founder of MapLight Therapeutics, Inc. and has been its President, Chief Executive Officer and Director from 2018. He serves as Director...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Christopher Kroeger
Founder
8.4yrs
US$25.62m
0.25% $ 3.3m
Robert Malenka
Co-Founder
no data
US$3.22m
0.48% $ 6.4m
Vishwas Setia
Chief Financial Officer
2.3yrs
US$6.20m
0.79% $ 10.4m
Erin Foff
Chief Medical Officer
5.1yrs
US$6.25m
0.76% $ 10.1m
Karoly Nikolich
Founder
no data
no data
no data
Karl Deisseroth
Co-Founder & Member of Scientific Advisory Board
no data
no data
no data
Jonathan Gillis
Chief Administrative & Accounting Officer
2.3yrs
no data
0.15% $ 2.0m
James Lillie
Chief Scientific Officer
7.3yrs
no data
0.54% $ 7.1m
Kristopher Hanson
General Counsel & Secretary
3.2yrs
no data
0.36% $ 4.8m
Anatol Kreitzer
Chief Discovery Officer
6yrs
no data
0.47% $ 6.2m
5.1yrs
Average Tenure
54yo
Average Age
Experienced Management: MPLT's management team is seasoned and experienced (5.1 years average tenure).
Board Members
Name
Position
Tenure
Compensation
Ownership
Christopher Kroeger
Founder
8.4yrs
US$25.62m
0.25% $ 3.3m
Robert Malenka
Co-Founder
less than a year
US$3.22m
0.48% $ 6.4m
Karl Deisseroth
Co-Founder & Member of Scientific Advisory Board
no data
no data
no data
Maria Walker
Independent Director
2.3yrs
US$895.18k
0.015% $ 197.4k
Timothy Garnett
Independent Director
2.9yrs
US$728.40k
0.026% $ 340.4k
Nanna Luneborg
Independent Director
less than a year
US$10.58k
no data
George Pavlov
Independent Chairman of the Board
7.3yrs
US$9.66k
0.055% $ 732.7k
Jim Trenkle
Independent Director
2.7yrs
no data
no data
Suzanne Hendrix
Member of Clinical Advisory Board
no data
no data
no data
Hongkui Zeng
Member of Scientific Advisory Board
3.2yrs
no data
no data
Ivan Soltesz
Member of Scientific Advisory Board
no data
no data
no data
Matthew State
Member of Scientific Advisory Board
no data
no data
no data
2.8yrs
Average Tenure
61yo
Average Age
Experienced Board: MPLT's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/01 17:40
End of Day Share Price
2026/06/01 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MapLight Therapeutics, Inc. is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.